Back
Empresa Distribuidora y Comercializadora Norte SA 10K Form
Sell
18
EDN
Empresa Distribuidora y Comercializadora Norte SA
Last Price:
$24.86
Seasonality Move:
8.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EDN News And Ratings
See the #1 stock for the next 7 days that we like better than EDN
EDN Financial Statistics
Sales & Book Value
Annual Sales: | $2.2B |
---|---|
Cash Flow: | $10.7M |
Price / Cash Flow: | 5.42 |
Annual Sales: | $35.82 |
Price / Book: | 0.68 |
Profitability
EPS (TTM): | 5.62690 |
---|---|
Net Income (TTM): | $246.2M |
Gross Margin: | $433.6M |
Return on Equity: | 20.48% |
Return on Assets: | 6.95% |
Empresa Distribuidora y Comercializadora Norte SA Earnings Forecast
Key Empresa Distribuidora y Comercializadora Norte SA Financial Ratios
-
The Gross Profit Margin over the past 22 years for EDN is 19.31%.
-
The Selling, General & Administrative Expenses for EDN have been equal to 13.41% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 122.73% of Operating Income.
-
The Net Earning history of EDN is 13.32% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 8 years.
Empresa Distribuidora y Comercializadora Norte SA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Electric Utilities |
Sector: | Utilities |
Current Symbol: | EDN |
CUSIP: | 29244A |
Website: | edenor.com |
Debt
Debt-to-Equity Ratio: | 0.27 |
---|---|
Current Ratio: | 0.85 |
Quick Ratio: | 0.7 |
Price-to-Earnings
Trailing P/E Ratio: | 3.58 |
---|---|
Forward P/E Ratio: | 160.79 |
EDN Technical Analysis vs Fundamental Analysis
Sell
18
Empresa Distribuidora y Comercializadora Norte SA (EDN)
is a Sell
Is Empresa Distribuidora y Comercializadora Norte SA a Buy or a Sell?
-
Empresa Distribuidora y Comercializadora Norte SA stock is rated a SellThe current Empresa Distribuidora y Comercializadora Norte SA [EDN] share price is $24.44. The Score for EDN is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.